David Dai Stock Analyst Profile - UBS Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    David Dai

    Stock Analyst at UBS

    (1.91)
    # 3295
    Out of 5,459 analysts
    29
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Consumer Cyclical
    Top Industries:
    Biotechnology Medical - Devices Specialty Retail
    21 Stocks
    Name Action PT Current % Upside Ratings Updated
    SNDX Syndax Pharmaceutica...
    Maintains: Buy
    37 35
    		16.26 115.25% 2 Jul 15, 2025
    NRIX Nurix Therapeutics
    Maintains: Buy
    30 26
    		9.55 172.25% 2 Jul 10, 2025
    SMMT Summit Therapeutics
    Initiates Coverage On: Buy
    30
    		24.8 20.97% 1 Jul 1, 2025
    BPMC Blueprint Medicines
    Maintains: Neutral
    88 129
    		129.46 -0.36% 2 Jun 5, 2025
    IOVA Iovance Biotherapeut...
    Downgrades: Neutral
    17 2
    		2.42 -17.36% 2 May 16, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    30 24
    		7.93 202.65% 2 May 12, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    100 100
    		76.13 31.35% 2 Mar 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    27 14
    		7.86 78.12% 2 Mar 6, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Sell
    24
    		32.65 -26.49% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    20
    		3.62 452.49% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    72
    		67.28 7.02% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    69
    		23.35 195.5% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    50
    		25 100% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    60
    		26.48 126.59% 1 Oct 24, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Feb 24, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    28
    		0.76 3584.21% 1 Mar 31, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    40
    		27.4 45.99% 1 Mar 16, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    40
    		1.72 2225.58% 1 Feb 4, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    50
    		2.24 2132.14% 1 Nov 18, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    41 52
    		30.82 68.72% 1 Mar 17, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    41
    		n/a n/a 1 Apr 25, 2017